-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
West syndrome, also known as infantile spasms, nodding eclampsia, etc.
First, the general overview
West syndrome is a group of symptoms
2.
Symptoms associated with West syndrome usually begin in the first year
Babies with West syndrome also have very abnormal electroencephalograms (EG), with high amplitude, chaotic spike patterns (low rhythm disorders
As they age, about one-third of children with West syndrome may develop recurrent seizures
3.
Approximately 70-75% of affected people can identify a specific cause of
The most common condition that causes West syndrome is tuberous sclerosis
X-linked West syndrome can be caused
Female carriers with X-linked disease have a 25% chance of having a carrier daughter like themselves per pregnancy, a 25% chance of having a non-carrier daughter, a 25% chance of having a son with the disease, and a 25% chance of having an unaffected son
4.
West syndrome is a rare neurological syndrome that can affect both men and women
It is estimated that 0.
5.
Symptoms of the following conditions may be similar
1.
Epilepsy is a group of neurological diseases
characterized by abnormal discharge of the brain.
It is characterized by loss of consciousness, convulsions, spasms, sensory confusion, and autonomic nervous system disorders
.
A "aura" usually appears before the seizure, i.
e.
a feeling of restlessness or feeling unwell; Aura marks the beginning
of a seizure in the brain.
There are many different types of epilepsy, the exact cause of which is usually
unknown.
Epileptic spasms are a type
of epilepsy.
2.
Lennox-Gastaut syndrome (LGS) is a rare form of epilepsy that usually becomes apparent
in infancy or early childhood.
This disease is characterized by seizures and, in many cases, an abnormal delay in the acquisition of skills that require the coordination of mental and muscular activity (psychomotor delay).
People with this disorder may experience several different types of seizures
.
Lennox-Gastaut syndrome may be caused by or associated
with a number of different underlying conditions or conditions.
See details: Lennox-Gastaut Syndrome: Signs and Symptoms, Etiology, Epidemiology, Diagnosis, and Treatment
3.
Myoclonic seizures can be seen in many types of epilepsy, from infantile myoclonic epilepsy to Dravet syndrome or myoclonic resting epilepsy, and are often confused
with infantile spasms.
These types of seizures are rapid twitches in the arms and legs, faster than infant spasms, and sometimes occur alone, rather than often in groups of epileptic cramps
.
Because epileptic cramps are very mild seizures, accompanied by small, brief movements of the trunk or arms, it is easy to misdiagnose as gastroesophageal reflux, constipation, behavioral, and other types of non-neurological disorders
.
Myoclonus is a neuromotor disorder in which there is a sudden involuntary muscle contraction
.
There are many different types of myoclonus, including some hereditary
.
Other causes include hypoxia, viruses, malignancies and central nervous system lesions, as well as drug and metabolic disorders
.
4.
Tuberous sclerosis (tuberous sclerosis) is mostly autosomal dominant, both men and women can suffer from the disease, and all lines of the body can be affected
.
Featured by facial sebaceous adenoma, seizures, and mental decline
.
Intracranial calcifications and upper ventricular wall calcifications are seen on X-ray of the skull, candle tears of the ventricular wall are seen on pneumocerebral angiography, and multifocal nodes and low-density changes or calcifications are seen in skull CT and MRI
.
See details: Tuberous sclerosis: signs and symptoms, etiology, epidemiology, diagnosis, and treatment
5.
Microcephaly is caused by
harmful environmental factors in the fetal period.
There are brain and skull and developmental disorders, after the completion of development of the brain weight does not exceed 1000 grams, the maximum circumference of the skull does not exceed 47 cm, the frontal and occipital parts are flat, narrow, the top is slightly pointed, and the well-developed facial bone forms a strong control
.
The scalp is thickened and the hair is thick.
Most of them are short in stature, and their intelligent development stops at the stage of
idiocy.
6.
Phenylketonuria is autosomal recessive and is an amino acid metabolism disease
.
Characterized by low intelligence and seizures, babies are usually normal at birth, gradually decrease in IQ after 1 to 6 months, and special odors such as musty or "rat" odors can be smelled in the body or clothing, and IQ declines rapidly after 6 months, and seizures manifest as infantile spasms or other forms of seizures
.
Plasma phenylalanine above 200 mg/ L is diagnostic
.
See: Phenylketonuria: Signs and Symptoms, Etiology, Epidemiology, Diagnosis, and Treatment
6.
Diagnosis
appraise
The first step is to characterize patterns of brain activity by using various devices to make measurements
.
These include:
Electroencephalogram (EEG):
This is a painless and non-invasive method
of recording patterns of electrical activity in the brain.
Electrodes are placed on the scalp and radio waves are picked up and recorded during activity, fortunately during
sleep.
If a pattern called hyperrhythmic disorders is noted, especially during sleep, this may help indicate that the patient has epileptic cramps
.
However, sometimes patients may have epileptic cramps and do not have a hyperarrhythmic pattern due to the lag time between clinical symptoms and EEG patterns
.
In addition, there are several diseases that can mimic epileptic spasms, and long-term video EEG can confirm the diagnosis of epileptic spasms
.
Therefore, in the setting of epileptic spasms, long-term video EEG monitoring at night is preferable to regular 20-minute EEG studies
.
Brain scans, such as computed
tomography
(CT).
X-rays from a computer can be used to generate a cross-section of the brain, from which details
of development can be determined.
CT is also very good at showing areas of calcification that may be critical to diagnosis in certain circumstances
.
However, this does not provide a picture
as detailed as MRI.
Magnetic resonance imaging (MRI
).
This radiation technique generates detailed images
of cross-sections or slices of the brain by using the magnetism of specific atoms found in the brain.
These images are more detailed than CT and can provide information
about any malformations in brain structures or other types of lesions common in epileptic cramps.
Infection as the cause of epileptic cramps can be identified
by blood tests, urine tests, and lumbar punctures.
Wood's lamp is used to examine the skin for pigment deficiency lesions to determine whether tuberous sclerosis is a possible diagnosis
.
Molecular genetic testing can be used for mutations
in the ARX and CDKL5 genes associated with X-linked West syndrome.
It can also be used for genes
associated with tuberous sclerosis.
Some genetic disorders require genetic testing
of cerebrospinal fluid (CSF).
Detection of non-ketotic hyperglycemia may require a sample of cerebrospinal fluid to detect glycine, and detection of mitochondrial disease may require cerebrospinal fluid to detect lactate
.
Mutations
in the STXBP1 gene have also recently been identified in patients with Otahara syndrome.
There are several genomes available that can test for various genetic conditions that occur in epilepsy in children of a specific age, such as epileptic cramps
.
7.
Treatment
Treatment may require a coordinated effort by a team of specialists
.
Pediatricians, neurologists, surgeons, and/or other healthcare professionals may need to plan the treatment
of affected children systematically and comprehensively.
In some children, treatment with anticonvulsants may help reduce or control the various seizure activities
associated with West syndrome.
The most common drugs used to treat epileptic cramps include adrenocorticotropic hormone (ACTH), prednisone, vigabatrin, and pyridoxine
.
The benefits of the drug need to be weighed
against the risk of side effects of each treatment.
For example, adrenocorticotropic hormones, prednisone, and other steroids are known to cause problems such as immunosuppression, high blood pressure, glucose, stomach problems, agitation, and irritability
.
Vigabatrin may cause irreversible visual field defects, irritability, and transient hyperintension of MRI deep structures
.
There is no standard protocol for treatment with ACTH or other steroids
.
It is unclear whether high-dose ACTH or low-dose ACTH is effective, or whether the use of prednisone is more effective
than ACTH.
In a recent multicenter study comparing steroid therapy with vigabatrin, it was suggested that steroids may have better control of seizures at 2 weeks of treatment than vigabatrin, but with the same
effect after one year.
In addition, vigabatrin is more effective
in patients with tuberous sclerosis or cortical dysplasia compared to steroids.
Recently, a multicenter European/Australian/New Zealand Consortium (ISCC) found that hormone therapy with vigabatrin was more effective at stopping infantile spasms
than hormone therapy alone.
Research
is underway in the United States on the combination of hormones and vigabatrin.
It is thought that the shorter time between diagnosis and treatment has less
harmful effects on development than longer treatment preparation times.
If these treatments are unsuccessful, other agents such as benzodiazepines (e.
g.
, clobazan), valproic acid, topiramate, lufiamide, and zonisamide
may be used.
The ketogenic diet is sometimes successful in treating epileptic cramps, with studies showing a rate of complete control of epileptic cramps as high as 35%.
Finally, in the case of malformations or tuberous sclerosis, epilepsy surgery may help control spasms
.
VIII.
Prognosis
Some children respond well to antiepileptic drugs, while others do not respond to
antiepileptic drugs.
The prognosis of infantile spasms depends primarily on the cause
.
The long-term prognosis is poor, more than 90% have varying degrees of psychomotor retardation, and many children develop other seizure types in the late childhood, which may develop Lennox-Gastaut syndrome
.
9.
Rare disease information registration
If you are willing to seek constantly updated information, it is recommended that you register the patient's information here, even if you are not fully diagnosed, you can register, click to enter:
Patient Information Registry System for Rare Diseases
Resources:
O’Callaghan FJ, Edwards SW, Alber FK, et al.
Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomized, multicenter, open-label trial.
Lancet Neurol.
2016 Nov 9; doi: 10.
1016/S1474-4422(16)30294-0.
Hancock EC, et al.
Treatment of infantile spasms.
Cochrane Database Syst Rev.
2013 Jun 5; 6 CD001770.
Hrachovy RA, et al.
Infantile spasms.
Handb Clin Neurol.
2013; 111: 611-8.
Lux AL.
Latest American and European updates on infantile spasms.
Curr Neurol Neurosci Rep.
2013 Mar; 13(3): 334.
Go CY, et al.
Evidence-based guideline update: medical treatment of infantile spasms.
Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
Neurology 2012 Jun 12; 78(24): 1974-80.
Pellock JM, et al.
Infantile spasms: a US consensus report.
Epilepsia.
2010; 51(10):2175-89 Riikonen RS.
Favourable prognostic factors with infantile spasms.
Eur J Paediatri neurol.
2010:14(1): 13-8.
Maguire MJ, et al.
Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review.
Epilepsia 2010:51(12):2423-31.
Djuric M, et al.
Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
Epilepsia 2014 Dec; 55 (12): 1918-25.
Hussain SA, et al.
Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone.
Epilepsia 2014 Jan; 55(1): 103-7.
Poulat AL, et al.
A proposed diagnostic approach for infantile spasms based on a spectrum of variable aetiology.
Eur J Paediatr Neurol.
2014 Mar; 18 92): 176-82.
Auvin S, et al.
Diagnosis delay in West syndrome: misdiagnosis and consequences.
Eur J Pedatric 2012 Nov; 171(11): 1695-701.
Mytinger JR, et al.
The current evaluation and treatment of infantile spasms among members of the Child Neurology Society.
J Child Neuro 2012 Oct; 28(10): 1289-94.
Caraballo RH, et al.
Infantile spasms without hypsarrythmia: a study of 16 cases.
Seizure.
Apr 2011.
20(3): 197-202.
O’Callaghan FJ.
et al.
The effect of lead time to treatment and of age of onset as evidence from the United Kingdom Infantile Spasms trial.
Epilepsia.
Jul 2011.
52(7): 1359-64.
Mohamed BP, et al.
Seizure outcome in infantile spasms- a retrospective study.
Epilepsia.
2011: 52(4):746-52.
Yum MS.
Surgical treatment for localization related infantile spasms.
Clinical Neurology and Neurosurgery.
Apr 2011.
113 (3):213-7.
Olson HE, et al.
Rufinamide for the treatment of epileptic spasms.
Epilepsy and Behavior.
Feb 2011.
20(2):344-8.
Hong AM, et al.
Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants.
Epilepsia 2010:51(8):1403-7.
Darke K, et al.
Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.
Arch Dis Child.
2010:95(5): 382-6.
Osborne, JP, et al.
The underlying etiology of infantile spasms (West syndrome) from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification.
Epilepsia.
Oct 2010.
51(10):2168-74.
Peltzer B, et al.
Topiramate and adrenocorticotropic hormone (ACTH) as initial treatment for infantile spasms.
J Child Neurol.
2009:24(4): 400-5.
Yum MS, et al.
Zonisamide in West syndrome: an open label study.
Epileptic Disord.
2009:11(4):339-44.
Lux, AL, et al.
The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicenter randomized trial.
Lancet Neurol 2005; 4:714-7.
Sherr EH.
The ARX story (epilepsy, mental retardation, autism, and cerebral malformations): one gene leads to many phenotypes.
Curr Opin Pediatr.
2003; 15(6):567-71.
Riikonen R.
Long-term outcome of patients with West syndrome.
Brain Dev.
2001; 23:683-87.
Online Mendelian Inheritance in Man (OMIM).
The Johns Hopkins University.
Epileptic Encephalopathy, Early Infantile, 1; EIEE1.
Entry No: 308350.
Last Edited: 02/18/2019.
http://omim.
org/entry/308350 Accessed March 11, 2019.
Glauser, TA.
Infantile Spasm (West Syndrome) Medscape.
Updated: Updated: Jan 11, 2019.
Accessed March 11, 2019.
https://rarediseases.
org/rare-diseases/west-syndrome/